Yahoo
XETRA - Delayed Quote EUR

Sartorius Aktiengesellschaft (SRT.DE)

229.00 -6.50 (-2.76%)
At close: October 30 at 5:35:02 PM GMT+1
Chart Range Bar
Loading chart for SRT.DE
  • Previous Close 235.50
  • Open 235.50
  • Bid 229.00 x 18800
  • Ask 230.00 x 13500
  • Day's Range 228.50 - 236.00
  • 52 Week Range 158.20 - 236.00
  • Volume 2,792
  • Avg. Volume 3,447
  • Market Cap (intraday) 15.813B
  • Beta (5Y Monthly) 1.45
  • PE Ratio (TTM) 71.56
  • EPS (TTM) 3.20
  • Earnings Date Oct 22, 2026
  • Forward Dividend & Yield 0.73 (0.31%)
  • Ex-Dividend Date Mar 27, 2026
  • 1y Target Est 263.97

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

www.sartorius.com

14,273

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

SRT.DE
20.42%
DAX P (^GDAXI)
5.42%

1-Year Return

SRT.DE
21.82%
DAX P (^GDAXI)
7.05%

3-Year Return

SRT.DE
27.66%
DAX P (^GDAXI)
75.44%

5-Year Return

SRT.DE
56.03%
DAX P (^GDAXI)
64.56%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 926.3M
Earnings 66.1M
Profit Margin 7.14%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
4.0%
5.0%
6.0%
7.0%

Analyst Insights

View More

Analyst Price Targets

68.75 Low
263.97 Average
229.00 Current
445.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/10/2020
Analyst Keybanc
Rating Action Initiated
Rating Sector Weight
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.96%

  • Return on Assets (ttm)

    4.23%

  • Return on Equity (ttm)

    7.86%

  • Revenue (ttm)

    3.66B

  • Net Income Avi to Common (ttm)

    218.5M

  • Diluted EPS (ttm)

    3.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    230.7M

  • Total Debt/Equity (mrq)

    94.36%

  • Levered Free Cash Flow (ttm)

    380.59M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: